Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1) a phase 3, randomised, double-blind, multicentre trial

Sara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Max S Mano; Silvia P Neciosup; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Shantha Rao; Lida Bubuteishvili Pacaud; Tetiana Taran; Dennis Slamon

The Lancet Oncology London v. 16, n. 7, p. 816-829, 2015

London 2015

Acesso online. A biblioteca também possui exemplares impressos.